Answers are grounded in this paper and cite their sources.
The present study reports the synthesis of Selenium nanoparticles (Se-NPs) through an eco-friendly method using guava leaf extract for their application in diabetes and wound healing. The synthesized nanoparticles were characterized by UV-Vis spectroscopy, Transmission electron microscopy, and Dynamic light scattering. TEM revealed the spherical morphology of Se-NPs and a size range of 2–5 nm. The Se-NPs inhibit carbohydrate digestive enzymes (alpha-amylase and glucosidase), which are key in managing intestinal glucose absorption. These Se-NPs exhibit IC50 values of 15 µg mL −1 for α-amylase and 21 µg mL −1 for α-glucosidase. These nanoparticles effectively adsorb glucose, and adsorption increases with an increase in glucose concentration. 10 mg mL −1 of nanoparticles can adsorb as low as 5 mmol of glucose. The study also explored Se-NPs' ability to enhance glucose uptake by human RBCs (hRBCs), akin to insulin mechanisms. At a concentration of 20 µg mL −1 of both Se-NPs and acarbose, glucose uptake by hRBCs is 83 %, which is higher than that of the standard drug acarbose (62 %). Additionally, cytotoxicity assays on human keratinocyte cells (HaCaT) demonstrated that Se-NPs have an IC50 value of 25 µg mL −1, which shows much lower toxicity compared to sodium selenite salt (3.6 µg mL −1 ). Further, the biocompatibility of Se-NPs was studied by measuring mitochondrial ROS, membrane potential, and cellular proliferation. In vitro wound healing assays indicated that at 15 µg mL −1 of Se-NPs, around 100 % of wound closure was achieved after 15 h, whereas the control without nanoparticles showed only 37 % wound closure. Overall, this research underscores the multifaceted biomedical applications of Se-NPs synthesized via guava leaf extract, suggesting promising avenues for future therapeutic development.
No takes yet. Share an insight, caveat, or question.
Mirza et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: